BIOTECHNOLOGY NEWS
ASSOCHAM for at least 3 SEZs in Goa
The Associated Chambers of Commerce and Industry of India requested the State government to reconsider its decision on Special Economic Zones and advocated creation of at least of three SEZs, in Goa.Three SEZs in bio and nano-technology, food processing and solar energy will help Goa attract investments up to Rs 50,000 crore and generate jobs for at least 20,000 youth, in next three years, ASSOCHAM said.
Biotechnology may get separate Ministry
The government is planning to upgrade the department of biotechnology (DBT) to the status of a full-fledged ministry. At present DBT is under the Union ministry of science and technology and is responsible for promoting researches for development of genetically modified (GM) crops and other biotechnological applications in agriculture and health sciences.
Source: - https://financialexpress.com
Betting on biotech
Twenty years after the creation of the department of biotechnology (DBT), the government of India approved a national biotechnology development strategy a few months ago. The policy, announced in November 2007, is an outcome of a two-year nationwide consultation process involving multiple stakeholders. The Indian biotech industry has only recently reached a respectable size and is growing at 30 per cent per annum.
Source: - https://timesofindia.indiatimes.com/
Generex Biotechnology (GNBT) Receives Indian Purchase Order for Generex Oral-lyn
Generex Biotechnology Corporation has received a Purchase Order for 210,000 canisters of Generex Oral-lyn(tm), the Company's proprietary oral insulin spray product, from Shreya Life Sciences Pvt. Ltd., the Company's distributor in India. This is the first Indian commercial order for the Company's flagship product. Generex Oral-lyn was approved for sale in India in late 2007 and is the first non-injectible buccal insulin to receive Indian approval. Source: - https://streetinsider.com
New 2008 BioWorld State of the Industry Report Released
The industry report measuring the progress of business, science and regulation in biotechnology has been released by Bioworld. This status-check on the biotechnology industry, published by BioWorld Today, is a required reference for analysts, investors and biotech executives in need of factual data that will help show them which way the sector is heading. Source:- https://bioworld.com
